Identification of miRNAs that specifically target tumor suppressive KLF6-FL rather than oncogenic KLF6-SV1 isoform

Wei Cheng Liang, Yan Wang, Li Jia Xiao, Yu Bing Wang, Wei Ming Fu, Wei Mao Wang, Hui Qing Jiang, Wei Qi, David Chi Cheong Wan, Jin Fang Zhang, Mary Miu Yee Waye

Research output: Contribution to journalArticlepeer-review

36 Scopus citations


The Krüppel like factor 6 (KLF6) gene encodes multiple protein isoforms derived from alternative mRNA splicing, most of which are intimately involved in hepatocarcinogenesis and tumor progression. Recent bioinformatics analysis shows that alternative mRNA splicing of the KLF6 gene produces around 16 alternatively spliced variants with divergent or even opposing functions. Intriguingly, the full-length KLF6 (KLF6-FL) is a tumor suppressor gene frequently inactivated in liver cancer, whereas KLF6 splice variant 1 (KLF6-SV1) is an oncogenic isoform with antagonistic function against KLF6-FL. Compelling evidence indicates that miRNA, the small endogenous non-coding RNA (ncRNA), acts as a vital player in modulating a variety of cellular biological processes through targeting different mRNA regions of protein-coding genes. To identify the potential miRNAs specifically targeting KLF6-FL, we utilized bioinformatics analysis in combination with the luciferase reporter assays and screened out two miRNAs, namely miR-210 and miR-1301, specifically targeted the tumor suppressive KLF6-FL rather than the oncogenic KLF6-SV1. Our in vitro experiments demonstrated that stable expression of KLF6-FL inhibited cell proliferation, migration and angiogenesis while overexpression of miR-1301 promoted cell migration and angiogenesis. Further experiments demonstrated that miR-1301 was highly expressed in liver cancer cell lines as well as clinical specimens and we also identified the potential methylation and histone acetylation for miR-1301 gene. To sum up, our findings unveiled a novel molecular mechanism that specific miRNAs promoted tumorigenesis by targeting the tumor suppressive isoform KLF6-FL rather than its oncogenic isoform KLF6-SV1.

Original languageEnglish (US)
Pages (from-to)845-854
Number of pages10
JournalRNA Biology
Issue number7
StatePublished - Jul 1 2014

Bibliographical note

Funding Information:
We are grateful to Prof. Scott L. Friedman, Prof. Yiu Loon Chui and Prof. Bin Guo for kindly providing pBabe-KLF6 vector, pCMV-KLF6 vector as well as pCL-Ampho packaging vector, respectively. We thank Prof. Weng Onn Lui (Karolinska Institutet, Sweden) for the helpful comments on the manuscript. This study was supported by the National Natural Science Foundation of China (81201699; 81372450) and the Croucher Foundation.

Publisher Copyright:
© 2014 Landes Bioscience.


  • Alternative splicing
  • KLF6
  • miRNA


Dive into the research topics of 'Identification of miRNAs that specifically target tumor suppressive KLF6-FL rather than oncogenic KLF6-SV1 isoform'. Together they form a unique fingerprint.

Cite this